Identification of a novel m6A-related lncRNAs signature and immunotherapeutic drug sensitivity in pancreatic adenocarcinoma
Abstract Background Pancreatic adenocarcinoma (PDAC) ranks as the fourth leading cause for cancer-related deaths worldwide. N6-methyladenosine (m6A) and long non-coding RNAs (lncRNAs) are closely related with poor prognosis and immunotherapeutic effect in PDAC. The aim of this study is to construct...
Main Authors: | Xia-Qing Li, Shi-Qi Yin, Lin Chen, Aziguli Tulamaiti, Shu-Yu Xiao, Xue-Li Zhang, Lei Shi, Xiao-Cao Miao, Yan Yang, Xin Xing |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-024-11885-8 |
Similar Items
-
The role of lncRNAs and exosomal lncRNAs in cancer metastasis
by: Yutong Zhang, et al.
Published: (2023-09-01) -
Identification of prognostic immune-related lncRNAs in pancreatic cancer
by: Yan Ma, et al.
Published: (2022-11-01) -
LncRNAs and CircRNAs in cancer
by: Xin Yin, et al.
Published: (2022-06-01) -
Integrated analysis of necroptosis-related lncRNAs for prognosis and immunotherapy of patients with pancreatic adenocarcinoma
by: Jiantao Mo, et al.
Published: (2022-08-01) -
Insights into the defensive roles of lncRNAs during Mycoplasma pneumoniae infection
by: Zhujun Yang, et al.
Published: (2024-03-01)